Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
Newsfilter· 2024-08-02 20:30
YARDLEY, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the second quarter 2024 and corporate updates, before market open, on Thursday, August 8, 2024. Company to Host Conference CallMembers of the Company's leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled ...
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Newsfilter· 2024-08-02 20:30
THE WOODLANDS, TX, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the next CEO Corner segment has been published on the Company's website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, discussed the Company's recently completed transaction with RF Innovations, Inc., a p ...
Arbor Realty Trust Reports Second Quarter 2024 Results and Declares Dividend of $0.43 per Share
Newsfilter· 2024-08-02 20:15
Company Highlights: GAAP net income of $0.25 and distributable earnings of $0.45, per diluted common share1Declares cash dividend on common stock of $0.43 per shareStrong liquidity position with ~$725 million in cash and liquidity and ~$215 million of CLO restricted cash2Agency loan originations of $1.15 billion; a servicing portfolio of ~$32.28 billion, up 3%Structured loan originations of $227.2 million, runoff of $629.6 million and a portfolio of ~$11.87 billionRedeemed our 5.75% senior notes at maturity ...
BETTER CHOICE PROVIDES POSITIVE PRELIMINARY RESULTS FOR THE SECOND QUARTER OF 2024
Newsfilter· 2024-08-02 20:05
Estimates $2.7 Million Net Income for Second Quarter 2024, a 190% Increase YOYEstimates Basic EPS of $2.98 per share for Second Quarter 2024, a 170% Increase YOYEstimates Halo Breaks Even at $0.02 Million Adj. EBITDA for First Half 2024, a 101% Increase YOY* TAMPA, FL, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE:BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced preliminary, key financial metrics guidance for the three months and six months en ...
Cumulus Media Reports Operating Results for the Second Quarter 2024
Newsfilter· 2024-08-02 20:01
Completed Highly Successful Debt Exchange That Reduced Our Debt Obligations Under Our Debt Instruments by Approximately $33 Million, Extended Maturities to 2029, Obtained Favorable Interest Rates, and Preserved Structure Free of Financial Maintenance Covenants Upsized ABL Facility by 25% to $125 Million and Extended Maturity to 2029 Reported Q2 Total Revenue of $205 Million, Down 2.5%, in Line with Pacing Guidance Increased Digital Marketing Services Revenue by 24%, Total Digital Revenue by 5% ATLANTA, Aug ...
Newmark Reports Second Quarter 2024 Financial Results
Prnewswire· 2024-08-02 20:01
Conference Call to Discuss Results Scheduled for 10:00 a.m. ET Today NEW YORK, Aug. 2, 2024 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, today, reported its financial results for the three and six months ended June 30, 2024, and declared its quarterly dividend. A complete and full-text financial results press release, includi ...
Hanover Bancorp Announces Small Business Recovery Grants to Local Non-Profit Organizations
Newsfilter· 2024-08-02 20:00
MINEOLA, N.Y., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Michael P. Puorro, Chairman and Chief Executive Officer of Hanover Bancorp, Inc. the bank holding company for Hanover Community Bank, today announced grants to seventeen local not-for-profit organizations as a part of the Federal Home Loan Bank of New York's (FHLBNY) Small Business Recovery Grant Program. Mr. Puorro stated "These organizations are the very heartbeat of the communities we serve, and we are thrilled that this money will help them in fulfilling ...
Agrify Reminds Stockholders to Vote Before the Proxy Voting Deadline for the Upcoming Annual Meeting of Stockholders
Newsfilter· 2024-08-02 20:00
BILLERICA, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), the most innovative provider of advanced cultivation and extraction solutions for the cannabis industry, would like to remind stockholders to cast their votes for the proposals that will be voted on at the Company's annual meeting of stockholders (the "Meeting") in advance of the proxy voting deadline for voting by telephone or electronically of 11:59 p.m. (Eastern Daylight Time) on Sunday, Augu ...
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
Newsfilter· 2024-08-02 20:00
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the FDA approval of the Inspire V therapy system which includes the next generation neurostimulator and the associated Bluetooth® patient remote and physician programmer. "We are thrilled to announce the FDA approval of our n ...
23andMe Special Committee responds to CEO's take-private proposal
Newsfilter· 2024-08-02 20:00
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and biopharmaceutical company, today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, in response to Ms. Wojcicki's previously disclosed preliminary non-binding indication of interest to acquire all of the outstanding shares of 23andMe not owned by her or her ...